img

Global Nanomedicine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Nanomedicine Market Insights, Forecast to 2034

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Market Analysis and InsightsGlobal Nanomedicine Market
Global Nanomedicine market is expected to reach to US$ 170.1 million in 2023, with a positive growth of %, compared with US$ 155.5 million in 2022. Backed with the increasing demand from downstream industries, Nanomedicine industry is evaluated to reach US$ 246.8 million in 2033. The CAGR will be 6.4% during 2023 to 2033.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.

Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.

In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.

Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
Report Covers
This report presents an overview of global Nanomedicine market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Nanomedicine market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Segment by Type
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices

Segment by Application


oncology
Infectious diseases
Cardiology
Orthopedics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nanomedicine introduction, etc. Nanomedicine Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Nanomedicine
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2018-2033)
2.2 Global Nanomedicine Growth Trends by Region
2.2.1 Nanomedicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Nanomedicine Historic Market Size by Region (2018-2023)
2.2.3 Nanomedicine Forecasted Market Size by Region (2024-2033)
2.3 Nanomedicine Market Dynamics
2.3.1 Nanomedicine Industry Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nanomedicine by Players
3.1.1 Global Nanomedicine Revenue by Players (2018-2023)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2018-2023)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nanomedicine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2022
3.5 Global Key Players of Nanomedicine Head office and Area Served
3.6 Global Key Players of Nanomedicine, Product and Application
3.7 Global Key Players of Nanomedicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2018-2023)
4.2 Global Nanomedicine Forecasted Market Size by Type (2024-2033)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2018-2023)
5.2 Global Nanomedicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nanomedicine Market Size (2018-2033)
6.2 North America Nanomedicine Market Size by Type
6.2.1 North America Nanomedicine Market Size by Type (2018-2023)
6.2.2 North America Nanomedicine Market Size by Type (2024-2033)
6.2.3 North America Nanomedicine Market Share by Type (2018-2033)
6.3 North America Nanomedicine Market Size by Application
6.3.1 North America Nanomedicine Market Size by Application (2018-2023)
6.3.2 North America Nanomedicine Market Size by Application (2024-2033)
6.3.3 North America Nanomedicine Market Share by Application (2018-2033)
6.4 North America Nanomedicine Market Size by Country
6.4.1 North America Nanomedicine Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Nanomedicine Market Size by Country (2018-2023)
6.4.3 North America Nanomedicine Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2018-2033)
7.2 Europe Nanomedicine Market Size by Type
7.2.1 Europe Nanomedicine Market Size by Type (2018-2023)
7.2.2 Europe Nanomedicine Market Size by Type (2024-2033)
7.2.3 Europe Nanomedicine Market Share by Type (2018-2033)
7.3 Europe Nanomedicine Market Size by Application
7.3.1 Europe Nanomedicine Market Size by Application (2018-2023)
7.3.2 Europe Nanomedicine Market Size by Application (2024-2033)
7.3.3 Europe Nanomedicine Market Share by Application (2018-2033)
7.4 Europe Nanomedicine Market Size by Country
7.4.1 Europe Nanomedicine Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Nanomedicine Market Size by Country (2018-2023)
7.4.3 Europe Nanomedicine Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nanomedicine Market Size (2018-2033)
8.2 China Nanomedicine Market Size by Type
8.2.1 China Nanomedicine Market Size by Type (2018-2023)
8.2.2 China Nanomedicine Market Size by Type (2024-2033)
8.2.3 China Nanomedicine Market Share by Type (2018-2033)
8.3 China Nanomedicine Market Size by Application
8.3.1 China Nanomedicine Market Size by Application (2018-2023)
8.3.2 China Nanomedicine Market Size by Application (2024-2033)
8.3.3 China Nanomedicine Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Nanomedicine Market Size (2018-2033)
9.2 Asia Nanomedicine Market Size by Type
9.2.1 Asia Nanomedicine Market Size by Type (2018-2023)
9.2.2 Asia Nanomedicine Market Size by Type (2024-2033)
9.2.3 Asia Nanomedicine Market Share by Type (2018-2033)
9.3 Asia Nanomedicine Market Size by Application
9.3.1 Asia Nanomedicine Market Size by Application (2018-2023)
9.3.2 Asia Nanomedicine Market Size by Application (2024-2033)
9.3.3 Asia Nanomedicine Market Share by Application (2018-2033)
9.4 Asia Nanomedicine Market Size by Region
9.4.1 Asia Nanomedicine Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Nanomedicine Market Size by Region (2018-2023)
9.4.3 Asia Nanomedicine Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nanomedicine Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Nanomedicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nanomedicine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Nanomedicine Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Nanomedicine Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Nanomedicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nanomedicine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Nanomedicine Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Nanomedicine Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Nanomedicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nanomedicine Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Nanomedicine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Nanomedicine Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Details
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2018-2023)
11.1.5 Combimatrix Recent Developments
11.2 Ablynx
11.2.1 Ablynx Company Details
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2018-2023)
11.2.5 Ablynx Recent Developments
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Details
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2018-2023)
11.3.5 Abraxis Bioscience Recent Developments
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2018-2023)
11.4.5 Celgene Recent Developments
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Details
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2018-2023)
11.5.5 Mallinckrodt Recent Developments
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Details
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2018-2023)
11.6.5 Arrowhead Research Recent Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2018-2023)
11.7.5 GE Healthcare Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2018-2023)
11.8.5 Merck Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2018-2023)
11.9.5 Pfizer Recent Developments
11.10 Nanosphere
11.10.1 Nanosphere Company Details
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2018-2023)
11.10.5 Nanosphere Recent Developments
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Details
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2018-2023)
11.11.5 Epeius Biotechnologies Recent Developments
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Details
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2018-2023)
11.12.5 Cytimmune Sciences Recent Developments
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Details
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2018-2023)
11.13.5 Nanospectra Biosciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Quantum dots
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Nanoshells
Table 5. Key Players of Nanotubes
Table 6. Key Players of Nanodevices
Table 7. Global Nanomedicine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Nanomedicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Nanomedicine Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Nanomedicine Market Share by Region (2018-2023)
Table 11. Global Nanomedicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Nanomedicine Market Share by Region (2024-2033)
Table 13. Nanomedicine Market Trends
Table 14. Nanomedicine Market Drivers
Table 15. Nanomedicine Market Challenges
Table 16. Nanomedicine Market Restraints
Table 17. Global Nanomedicine Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Nanomedicine Revenue Share by Players (2018-2023)
Table 19. Global Top Nanomedicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)
Table 20. Global Nanomedicine Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Nanomedicine, Headquarters and Area Served
Table 23. Global Key Players of Nanomedicine, Product and Application
Table 24. Global Key Players of Nanomedicine, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Nanomedicine Revenue Market Share by Type (2018-2023)
Table 28. Global Nanomedicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Nanomedicine Revenue Market Share by Type (2024-2033)
Table 30. Global Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Nanomedicine Revenue Share by Application (2018-2023)
Table 32. Global Nanomedicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Nanomedicine Revenue Share by Application (2024-2033)
Table 34. North America Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Nanomedicine Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Nanomedicine Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Nanomedicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Nanomedicine Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Nanomedicine Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Nanomedicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Nanomedicine Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Nanomedicine Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Nanomedicine Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Nanomedicine Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Nanomedicine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Nanomedicine Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Nanomedicine Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Nanomedicine Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nanomedicine Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nanomedicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 66. Combimatrix Company Details
Table 67. Combimatrix Business Overview
Table 68. Combimatrix Nanomedicine Product
Table 69. Combimatrix Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 70. Combimatrix Recent Developments
Table 71. Ablynx Company Details
Table 72. Ablynx Business Overview
Table 73. Ablynx Nanomedicine Product
Table 74. Ablynx Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 75. Ablynx Recent Developments
Table 76. Abraxis Bioscience Company Details
Table 77. Abraxis Bioscience Business Overview
Table 78. Abraxis Bioscience Nanomedicine Product
Table 79. Abraxis Bioscience Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 80. Abraxis Bioscience Recent Developments
Table 81. Celgene Company Details
Table 82. Celgene Business Overview
Table 83. Celgene Nanomedicine Product
Table 84. Celgene Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 85. Celgene Recent Developments
Table 86. Mallinckrodt Company Details
Table 87. Mallinckrodt Business Overview
Table 88. Mallinckrodt Nanomedicine Product
Table 89. Mallinckrodt Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 90. Mallinckrodt Recent Developments
Table 91. Arrowhead Research Company Details
Table 92. Arrowhead Research Business Overview
Table 93. Arrowhead Research Nanomedicine Product
Table 94. Arrowhead Research Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 95. Arrowhead Research Recent Developments
Table 96. GE Healthcare Company Details
Table 97. GE Healthcare Business Overview
Table 98. GE Healthcare Nanomedicine Product
Table 99. GE Healthcare Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 100. GE Healthcare Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Nanomedicine Product
Table 104. Merck Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Nanomedicine Product
Table 109. Pfizer Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 110. Pfizer Recent Developments
Table 111. Nanosphere Company Details
Table 112. Nanosphere Business Overview
Table 113. Nanosphere Nanomedicine Product
Table 114. Nanosphere Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 115. Nanosphere Recent Developments
Table 116. Epeius Biotechnologies Company Details
Table 117. Epeius Biotechnologies Business Overview
Table 118. Epeius Biotechnologies Nanomedicine Product
Table 119. Epeius Biotechnologies Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 120. Epeius Biotechnologies Recent Developments
Table 121. Cytimmune Sciences Company Details
Table 122. Cytimmune Sciences Business Overview
Table 123. Cytimmune Sciences Nanomedicine Product
Table 124. Cytimmune Sciences Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 125. Cytimmune Sciences Recent Developments
Table 126. Nanospectra Biosciences Company Details
Table 127. Nanospectra Biosciences Business Overview
Table 128. Nanospectra Biosciences Nanomedicine Product
Table 129. Nanospectra Biosciences Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 130. Nanospectra Biosciences Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Nanomedicine Market Share by Type: 2022 VS 2033
Figure 3. Quantum dots Features
Figure 4. Nanoparticles Features
Figure 5. Nanoshells Features
Figure 6. Nanotubes Features
Figure 7. Nanodevices Features
Figure 8. Global Nanomedicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Nanomedicine Market Share by Application: 2022 VS 2033
Figure 10. oncology Case Studies
Figure 11. Infectious diseases Case Studies
Figure 12. Cardiology Case Studies
Figure 13. Orthopedics Case Studies
Figure 14. Others Case Studies
Figure 15. Nanomedicine Report Years Considered
Figure 16. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Nanomedicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Nanomedicine Market Share by Region: 2022 VS 2033
Figure 19. Global Nanomedicine Market Share by Players in 2022
Figure 20. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2022
Figure 22. North America Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Nanomedicine Market Share by Type (2018-2033)
Figure 24. North America Nanomedicine Market Share by Application (2018-2033)
Figure 25. North America Nanomedicine Market Share by Country (2018-2033)
Figure 26. United States Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Nanomedicine Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Nanomedicine Market Share by Type (2018-2033)
Figure 30. Europe Nanomedicine Market Share by Application (2018-2033)
Figure 31. Europe Nanomedicine Market Share by Country (2018-2033)
Figure 32. Germany Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Nanomedicine Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Nanomedicine Market Share by Type (2018-2033)
Figure 40. China Nanomedicine Market Share by Application (2018-2033)
Figure 41. Asia Nanomedicine Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Nanomedicine Market Share by Type (2018-2033)
Figure 43. Asia Nanomedicine Market Share by Application (2018-2033)
Figure 44. Asia Nanomedicine Market Share by Region (2018-2033)
Figure 45. Japan Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Nanomedicine Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Nanomedicine Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Nanomedicine Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Nanomedicine Market Share by Country (2018-2033)
Figure 55. Brazil Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Combimatrix Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 62. Ablynx Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 63. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 64. Celgene Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 65. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 66. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 67. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 69. Pfizer Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 70. Nanosphere Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 71. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 72. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 73. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries